SCHEMBL5202785

SCHEMBL5202785

O=C(NO)c1ncc[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2213386 0.81
SCHEMBL1857157 0.81
SCHEMBL1822218 0.81
SCHEMBL2994680 0.79 NPC1 (0.47)
SCHEMBL5174804 0.78 NPC1 (0.42)
SCHEMBL7215379 0.78 NPC1 (0.42)
Benzene SCHEMBL5151418 0.78 NPC1 (0.46)
SCHEMBL11701226 0.78 NPC1 (0.42)
SCHEMBL8904856 0.77
SCHEMBL1324 0.77 NPC1 (0.62)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230056785-A1 GAS-STORING MATERIAL INCLUDING METAL/ORGANIC FRAMEWORK BONDED BY HYDROXAMIC ACID RIKKYO EDUCATIONAL CORPORATION (JP) 2023-02-23 US disclosed
EP-1439220-B1 Immobilized biocatalysts usable for the manufacture of natural nucleosides and modified analogues through enzymatic transglycosylation reactions ADORKEM TECHNOLOGY SPA (IT) 2007-08-22 EP disclosed
US-20040142438-A1 Novel immobilized biocatalysts usable for the production of natural nucleosides and modified analogues by enzymatic transglycosylation reactions KERYOS SPA (IT) 2004-07-22 US disclosed
EP-1439220-A1 Immobilized biocatalysts usable for the manufacture of natural nucleosides and modified analogues through enzymatic transglycosylation reactions Keryos Spa (IT) 2004-07-21 EP disclosed
WO-1991011999-A1 ANGIOTENSIN II ANTAGONISTS INCORPORATING A SUBSTITUTED BENZYL ELEMENT MERCK & CO., INC. (US) 1991-08-22 WO disclosed